Anchor Capital Advisors Lowers stake in St. Jude Medical (STJ)

St. Jude Medical (STJ) : Anchor Capital Advisors reduced its stake in St. Jude Medical by 2.12% during the most recent quarter end. The investment management company now holds a total of 1,381,256 shares of St. Jude Medical which is valued at $104,616,329 after selling 29,935 shares in St. Jude Medical , the firm said in a disclosure report filed with the SEC on May 9, 2016.St. Jude Medical makes up approximately 2.66% of Anchor Capital Advisors’s portfolio.

Other Hedge Funds, Including , Advantus Capital Management Inc boosted its stake in STJ in the latest quarter, The investment management firm added 226 additional shares and now holds a total of 27,415 shares of St. Jude Medical which is valued at $2,076,412. St. Jude Medical makes up approx 0.06% of Advantus Capital Management Inc’s portfolio.Parkside Financial Bank Trust boosted its stake in STJ in the latest quarter, The investment management firm added 19 additional shares and now holds a total of 52 shares of St. Jude Medical which is valued at $3,905.Nisa Investment Advisors L.l.c. boosted its stake in STJ in the latest quarter, The investment management firm added 10,890 additional shares and now holds a total of 76,695 shares of St. Jude Medical which is valued at $5,844,159. St. Jude Medical makes up approx 0.08% of Nisa Investment Advisors L.l.c.’s portfolio.Td Securities (usa) boosted its stake in STJ in the latest quarter, The investment management firm added 1 additional shares and now holds a total of 64 shares of St. Jude Medical which is valued at $4,877. St. Jude Medical makes up approx 0.04% of Td Securities (usa)’s portfolio.Acropolis Investment Management boosted its stake in STJ in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 4,341 shares of St. Jude Medical which is valued at $330,784. St. Jude Medical makes up approx 0.06% of Acropolis Investment Management’s portfolio.

St. Jude Medical closed down -0.09 points or -0.12% at $75.74 with 45,13,625 shares getting traded on Friday. Post opening the session at $75.68, the shares hit an intraday low of $75.575 and an intraday high of $76.2 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, St. Jude Medical reported $0.90 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $0.88. The company had revenue of $1448.00 million for the quarter, compared to analysts expectations of $1437.78 million. The company’s revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.

Many Wall Street Analysts have commented on St. Jude Medical. St. Jude Medical was Downgraded by Sun Trust Rbsn Humphrey to ” Neutral” on May 10, 2016. St. Jude Medical was Downgraded by Credit Suisse to ” Neutral” on May 3, 2016. St. Jude Medical was Downgraded by Morgan Stanley to ” Equal-Weight” on May 2, 2016.

St. Jude Medical Inc. develops manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management cardiovascular and atrial fibrillation therapy areas and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems bradycardia pacemaker systems atrial fibrillation (AF) products (electrophysiology introducers and catheters advanced cardiac mapping navigation and recording systems and ablation systems) vascular products (vascular closure products pressure measurement guidewires optical coherence tomography (OCT) imaging products heart failure monitoring device and other vascular accessories) structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Leave a Reply

St. Jude Medical - Is it time to Sell?

Top Brokerage Firms are advising their investors on St. Jude Medical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.